Increased Iron Deposition on Brain Quantitative Susceptibility Mapping Correlates with Decreased Cognitive Function in Alzheimer's Disease

ACS Chemical Neuroscience

Volumn 9, Issue 7, 2018, Pages 1849-1857

  Du, Lei ^a   Zhao, Zifang ^a   Cui, Ailing ^b   Zhu, Yijiang ^c   Zhang, Lu ^d   Liu, Jing ^a   Shi, Sumin ^a   Fu, Chao ^a   Han, Xiaowei ^a   Gao, Wenwen ^a   Song, Tianbin ^e   Xie, Lizhi ^f   Wang, Lei ^a   Sun, Shilong ^a   Guo, Runcai ^a   Ma, Guolin ^a  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b CHANGZHI MEDICAL COLLEGE   (China)

^c ANHUI PROVINCIAL HOSPITAL   (China)

^d Shangluo Central Hospital   (China)

^e CAPITAL MEDICAL UNIVERSITY   (China)

^f GE HEALTHCARE   (China)

Author keywords

Alzheimer's disease; cognitive function; deep gray matter nuclei; mini mental state examination; Montreal cognitive assessment; quantitative susceptibility mapping

Indexed keywords

IRON;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN MAPPING; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DENTATE NUCLEUS; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; MAGNETISM; MALE; MINI MENTAL STATE EXAMINATION; MONTREAL COGNITIVE ASSESSMENT; NEUROIMAGING; NORMAL VALUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; QUANTITATIVE SUSCEPTIBILITY MAPPING; RED NUCLEUS; SEX DIFFERENCE; SUBSTANTIA NIGRA; THALAMUS; BRAIN; COHORT ANALYSIS; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC IMAGING; METABOLISM; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; SEVERITY OF ILLNESS INDEX;

AGED; ALZHEIMER DISEASE; BRAIN; COGNITION; COHORT STUDIES; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 85046668797     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.8b00194     Document Type: Article

References (65)

1. Albertini, V., Benussi, L., Paterlini, A., Glionna, M., Prestia, A., Bocchio-Chiavetto, L., Amicucci, G., Galluzzi, S., Adorni, A., Geroldi, C., Binetti, G., Frisoni, G. B., and Ghidoni, R. (2012) Distinct cerebrospinal fluid amyloid-beta peptide signatures in cognitive decline associated with Alzheimer's disease and schizophrenia. Electrophoresis 33, 3738-3744, 10.1002/elps.201200307
2. Jahn, H. (2013) Memory loss in Alzheimer's disease. Dialogues Clin Neuro. 15, 445-454
3. Hwang, E. J., Kim, H. G., Kim, D., Rhee, H. Y., Ryu, C. W., Liu, T., Wang, Y., and Jahng, G. H. (2016) Texture analyses of quantitative susceptibility maps to differentiate Alzheimer's disease from cognitive normal and mild cognitive impairment. Med. Phys. 43, 4718-4728, 10.1118/1.4958959
4. Wang, D., Li, Y. Y., Luo, J. H., and Li, Y. (2014) Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging. Arch. Gerontol. Geriatr. 59, 439-449, 10.1016/j.archger.2014.04.002
5. McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Jr, Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, B., Weintraub, S., and Phelps, C. H. (2011) The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dementia 7, 263-269, 10.1016/j.jalz.2011.03.005
6. Li, W., Langkammer, C., Chou, Y. H., Petrovic, K., Schmidt, R., Song, A. W., Madden, D. J., Ropele, S., and Liu, C. (2015) Association between increased magnetic susceptibility of deep gray matter nuclei and decreased motor function in healthy adults. NeuroImage 105, 45-52, 10.1016/j.neuroimage.2014.10.009
7. Moos, T. and Morgan, E. H. (2004) The metabolism of neuronal iron and its pathogenic role in neurological disease. Ann. N. Y. Acad. Sci. 1012, 14-26, 10.1196/annals.1306.002
8. Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R., and Crichton, R. R. (2004) Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863, 10.1038/nrn1537
9. Connor, J. R., Menzies, S. L., Burdo, J. R., and Boyer, P. J. (2001) Iron and iron management proteins in neurobiology. Pediatr Neurol. 25, 118-129, 10.1016/S0887-8994(01)00303-4
10. Munoz, P. and Humeres, A. (2012) Iron deficiency on neuronal function. BioMetals 25, 825-835, 10.1007/s10534-012-9550-x
11. Emerit, J., Beaumont, C., and Trivin, F. (2001) Iron metabolism, free radicals, and oxidative injury. Biomed. Pharmacother. 55, 333-339, 10.1016/S0753-3322(01)00068-3
12. Smith, M. A., Harris, P. L. R., Sayre, L. M., and Perry, G. (1997) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl. Acad. Sci. U. S. A. 94, 9866-9868, 10.1073/pnas.94.18.9866
13. Kell, D. B. (2010) Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 84, 825-889, 10.1007/s00204-010-0577-x
14. Bolt, H. M. and Marchan, R. (2010) Iron dysregulation: an important aspect in toxicology. Arch. Toxicol. 84, 823-824, 10.1007/s00204-010-0610-0
15. Du, G., Liu, T., Lewis, M. M., Kong, L., Wang, Y., Connor, J., Mailman, R. B., and Huang, X. (2016) Quantitative susceptibility mapping of the midbrain in Parkinson's disease. Mov. Disord. 31, 317-324, 10.1002/mds.26417
16. Murakami, Y., Kakeda, S., Watanabe, K., Ueda, I., Ogasawara, A., Moriya, J., Ide, S., Futatsuya, K., Sato, T., Okada, K., Uozumi, T., Tsuji, S., Liu, T., Wang, Y., and Korogi, Y. (2015) Usefulness of quantitative susceptibility mapping for the diagnosis of Parkinson disease. AJNR Am. J. Neuroradiol. 36, 1102-1108, 10.3174/ajnr.A4260
17. Acosta-Cabronero, J., Williams, G. B., Cardenas-Blanco, A., Arnold, R. J., Lupson, V., and Nestor, P. J. (2013) In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS One 8, e81093, 10.1371/journal.pone.0081093
18. Connor, J. R., Menzies, S. L., St. Martin, S. M., and Mufson, E. J. (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83, 10.1002/jnr.490310111
19. Grundke-Iqbal, I., Fleming, J., Tung, Y. C., Lassmann, H., Iqbal, K., and Joshi, J. G. (1990) Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol. 81, 105-110, 10.1007/BF00334497
20. LeVine, S. M. (1997) Iron deposits in multiple sclerosis and Alzheimer's disease brains. Brain Res. 760, 298-303, 10.1016/S0006-8993(97)00470-8
21. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., and Markesbery, W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47-52, 10.1016/S0022-510X(98)00092-6
22. Good, P. F., Perl, D. P., Bierer, L. M., and Schmeidler, J. (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 286-292, 10.1002/ana.410310310
23. Meadowcroft, M. D., Connor, J. R., Smith, M. B., and Yang, Q. X. (2009) MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J. Magn Reson Imaging. 29, 997-1007, 10.1002/jmri.21731
24. Peters, D. G., Connor, J. R., and Meadowcroft, M. D. (2015) The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin. Neurobiol. Dis. 81, 49-65, 10.1016/j.nbd.2015.08.007
25. Wan, L., Nie, G., Zhang, J., Luo, Y., Zhang, P., Zhang, Z., and Zhao, B. (2011) β-Amyloid peptide increases levels of iron content and oxidative stress in human cell and Caenorhabditis elegans, models of Alzheimer disease. Free Radical Biol. Med. 50, 122-129, 10.1016/j.freeradbiomed.2010.10.707
26. Goodman, L. (1953) Alzheimer's disease; a clinico-pathologic analysis of twenty-three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 118, 97-130, 10.1097/00005053-195308000-00001
27. Deibel, M. A., Ehmann, W. D., and Markesbery, W. R. (1996) Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 143, 137-142, 10.1016/S0022-510X(96)00203-1
28. Dedman, D. J., Treffry, A., Candy, J. M., Taylor, G. A. A., Morris, C. M., Bloxham, C. A., Perry, R. H., Edwardson, J. A., and Harrison, P. M. (1992) Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients. Biochem. J. 287, 509-514, 10.1042/bj2870509
29. Raven, E. P., Lu, P. H., Tishler, T. A., Heydari, P., and Bartzokis, G. (2013) Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer's disease detected in vivo with magnetic resonance imaging. J. Alzheimers Dis. 37, 127-136, 10.3233/JAD-130209
30. Schenck, J. F. and Zimmerman, E. A. (2004) High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed. 17, 433-445, 10.1002/nbm.922
31. Haacke, E. M., Cheng, N. Y. C., House, M. J., Liu, Q., Neelavalli, J., Ogg, R. J., Khan, A., Ayaz, M., Kirsch, W., and Obenaus, A. (2005) Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 23, 1-25, 10.1016/j.mri.2004.10.001
32. Reichenbach, J. R. (2012) The future of susceptibility contrast for assessment of anatomy and function. NeuroImage 62, 1311-1315, 10.1016/j.neuroimage.2012.01.004
33. Deistung, A., Schäfer, A., Schweser, F., Biedermann, U., Turner, R., and Reichenbach, J. R. (2013) Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R 2·-imaging at ultra-high magnetic field strength. NeuroImage 65, 299-314, 10.1016/j.neuroimage.2012.09.055
34. Lim, I. A. L., Faria, A. V., Li, X., Hsu, J. T., Airan, R. D., Mori, S., and van Zijl, P. C. (2013) Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures. NeuroImage 82, 449-469, 10.1016/j.neuroimage.2013.05.127
35. Schenck, J. F. (1996) The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med. Phys. 23, 815-850, 10.1118/1.597854
36. Schweser, F., Deistung, A., Lehr, B. W., and Reichenbach, J. R. (2011) Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?. NeuroImage 54, 2789-2807, 10.1016/j.neuroimage.2010.10.070
37. Langkammer, C., Schweser, F., Krebs, N., Deistung, A., Goessler, W., Scheurer, E., Sommer, K., Reishofer, G., Yen, K., Fazekas, F., Ropele, S., and Reichenbach, J. R. (2012) Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 62, 1593-1599, 10.1016/j.neuroimage.2012.05.049
38. Sun, H., Walsh, A. J., Lebel, R. M., Blevins, G., Catz, I., Lu, J. Q., Johnson, E. S., Emery, D. J., Warren, K. G., and Wilman, A. H. (2015) Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter. NeuroImage 105, 486-492, 10.1016/j.neuroimage.2014.11.010
39. Khalil, M., Enzinger, C., Langkammer, C., Ropele, S., Mader, A., Trentini, A., Vane, M. L., Wallner-Blazek, M., Bachmaier, G., Archelos, J. J., Koel-Simmelink, M. J., Blankenstein, M. A., Fuchs, S., Fazekas, F., and Teunissen, C. E. (2013) CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome. Mult Scler J. 19, 436-442, 10.1177/1352458512458010
40. Liu, P., Cui, Y., Na, J., and Gao, P. Y. (2010) Cerebral microbleeds-prevalence, distribution and risk factors in northeast population without preceding large-area stroke. Chinese Med. J-Peking. 123, 286-290
41. Lodygensky, G. A., Marques, J. P., Maddage, R., Perroud, E., Sizonenko, S. V., Hüppi, P. S., and Gruetter, R. (2012) In vivo assessment of myelination by phase imaging at high magnetic field. NeuroImage 59, 1979-1987, 10.1016/j.neuroimage.2011.09.057
42. Zhong, K., Ernst, T., Buchthal, S., Speck, O., Anderson, L., and Chang, L. (2011) Phase contrast imaging in neonates. NeuroImage 55, 1068-1072, 10.1016/j.neuroimage.2010.11.086
43. Haacke, E. M., Xu, Y., Cheng, Y. C. N., and Reichenbach, J. R. (2004) Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52, 612-618, 10.1002/mrm.20198
44. Shmueli, K., de Zwart, J. A., van Gelderen, P., Li, T. Q., Dodd, S. J., and Duyn, J. H. (2009) Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn. Reson. Med. 62, 1510-1522, 10.1002/mrm.22135
45. Schäfer, A., Wharton, S., Gowland, P., and Bowtell, R. (2009) Using magnetic field simulation to study susceptibility-related phase contrast in gradient echo MRI. NeuroImage 48, 126-137, 10.1016/j.neuroimage.2009.05.093
46. Sun, H. and Wilman, A. H. (2014) Background field removal using spherical mean value filtering and Tikhonov regularization. Magn. Reson. Med. 71, 1151-1157, 10.1002/mrm.24765
47. Wen, Y., Wang, Y., and Liu, T. (2016) Enhancing k-space quantitative susceptibility mapping by enforcing consistency on the cone data (CCD) with structural priors. Magn. Reson. Med. 75, 823-830, 10.1002/mrm.25652
48. Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V., and Adalsteinsson, E. (2012) MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. NeuroImage 59, 2625-2635, 10.1016/j.neuroimage.2011.08.077
49. Kim, H. G., Park, S., Rhee, H. Y., Lee, K. M., Ryu, C. W., Rhee, S. J., Lee, S. Y., Wang, Y., and Jahng, G. H. (2017) Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease. Neuroimage Clin. 16, 429-438, 10.1016/j.nicl.2017.08.019
50. Moon, Y., Han, S. H., and Moon, W. J. (2016) Patterns of brain iron accumulation in vascular dementia and Alzheimer's dementia using quantitative susceptibility mapping imaging. J. Alzheimer's Dis. 51, 737-745, 10.3233/JAD-151037
51. Gutteridge, J. (2001) Iron and oxygen radicals in brain. Ann. Neurol. 32 (1992), S16-21, 10.1002/ana.410320705
52. Rouault, T. A. (2001) Iron on the brain. Nat. Genet. 28, 299-300, 10.1038/91036
53. Petty, R. G., Bonner, D., Mouratoglou, V., and Silverman, M. (1996) Acute frontal lobe syndrome and dyscontrol associated with bilateral caudate nucleus infarctions. Br. J. Psychiatry 168, 237-240, 10.1192/bjp.168.2.237
54. Persson, N., Wu, J., Zhang, Q., Liu, T., Shen, J., Bao, R., Ni, M., Liu, T., Wang, Y., and Spincemaille, P. (2015) Age and sex related differences in subcortical brain iron concentrations among healthy adults. NeuroImage 122, 385-398, 10.1016/j.neuroimage.2015.07.050
55. Pietracupa, S., Martin-Bastida, A., and Piccini, P. (2017) Iron metabolism and its detection through mri in parkinsonian disorders: a systematic review. Neurol. Sci. 38, 2095, 10.1007/s10072-017-3099-y
56. Aquino, D., Bizzi, A., Grisoli, M., Garavaglia, B., Bruzzone, M. G., Nardocci, N., Savoiardo, M., and Chiapparini, L. (2009) Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 252, 165-172, 10.1148/radiol.2522081399
57. Akhlaghpoor, S., Ghahari, A., Morteza, A., Khalilzadeh, O., Shakourirad, A., and Alinaghizadeh, M. R. (2012) Quantitative T2∗ magnetic resonance imaging for evaluation of iron deposition in the brain of β-thalassemia patients. Clin Neuroradiol. 22, 211-217, 10.1007/s00062-011-0108-z
58. Xu, X., Wang, Q., and Zhang, M. (2008) Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. NeuroImage 40, 35-42, 10.1016/j.neuroimage.2007.11.017
59. Wang, D., Zhu, D., Wei, X. E., Li, Y. H., and Li, W. B. (2013) Using susceptibility-weighted images to quantify iron deposition differences in amnestic mild cognitive impairment and Alzheimer's disease. Neurol. India 61, 26-34, 10.4103/0028-3886.107924
60. Sánchez-Castaneda, C., Squitieri, F., Di Paola, M., Dayan, M., Petrollini, M., and Sabatini, U. (2015) The role of iron in gray matter degeneration in Huntington's disease: a magnetic resonance imaging study. Hum Brain Mapp. 36, 50-66, 10.1002/hbm.22612
61. Bartzokis, G., Lu, P. H., Tishler, T. A., Fong, S. M., Oluwadara, B., Finn, J. P., Huang, D., Bordelon, Y., Mintz, J., and Perlman, S. (2007) Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem. Res. 32, 1655-1664, 10.1007/s11064-007-9352-7
62. Hachinski, V. C., Iliff, L. D., Zilhka, E., Du Boulay, G. H., Mcallister, V. L., Marshall, J., Russell, R. W., and Symon, L. (1975) Cerebral blood flow in dementia. Arch. Neurol. 32, 632-637, 10.1001/archneur.1975.00490510088009
63. Matsuda, H. (2001) Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann. Nucl. Med. 15, 85-92, 10.1007/BF02988596
64. Zhang, Y., Zhang, J., Hsu, J., Oishi, K., Faria, A. V., Albert, M., Miller, M. I., and Mori, S. (2014) Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): application to normal and Alzheimer's populations. NeuroImage 84, 406-419, 10.1016/j.neuroimage.2013.09.011
65. Oppo, K., Leen, E., Angerson, W. J., Cooke, T. G., and McArdle, C. S. (1998) Doppler perfusion index: an interobserver and intraobserver reproducibility study. Radiology 208, 453-457, 10.1148/radiology.208.2.9680575